We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Blocklisting Six Monthly Return

2 Jun 2015 17:10

RNS Number : 0061P
Premier Veterinary Group PLC
02 June 2015
 



 

Premier Veterinary Group plc

 

2 June 2015

 

BLOCKLISTING SIX MONTHLY RETURN

 

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

2,271,252

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

2,271,252

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

939,433

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

683,200

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

683,200

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no awards outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

BLOCKLISTING SIX MONTHLY RETURN

 

1. Name of applicant

Premier Veterinary Group plc (formerly known as Ark Therapeutics Group plc)

2. Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3. Period of return

From 03/12/2014 - 02/06/2015

4. Balance of unallotted securities under scheme from previous return

1,000,000

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6. Less: Number of securities issued/allotted under the scheme during period

Nil

7. Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

 

NOTES:

 

· The number of shares stated represent the position prior to the share reorganisation which took effect on 13/12/2015.

 

· There are no options outstanding under this plan which has now expired. The block listing is, therefore, now closed.

 

 

Name of contact:

Sue Steven, Company Secretary

Telephone number of contact:

+44(0)117 970 4127

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLREAKKAEENSEFF
Date   Source Headline
1st Mar 201310:50 amRNSForm 8.3 - [Ark Therapeutics]
26th Feb 20135:35 pmRNSHolding(s) in Company
26th Feb 20139:33 amRNSForm 8.3 - Ark Therapeutics Group PLC
25th Feb 201311:55 amRNSForm 8.3 - Ark Therapeutics Group PLC
25th Feb 201311:27 amRNSHolding(s) in Company
22nd Feb 20132:41 pmRNSHolding(s) in Company
21st Feb 20131:24 pmPRNForm 8.3 - Ark Therapeutics plc
21st Feb 201310:56 amRNSHolding(s) in Company
20th Feb 201312:54 pmPRNForm 8.3 - Ark Therapeutics plc
20th Feb 201312:11 pmRNSForm 8.3 - [Ark Therapeutics Group PLC]
19th Feb 20134:40 pmRNSSecond Price Monitoring Extn
19th Feb 20134:35 pmRNSPrice Monitoring Extension
15th Feb 201312:57 pmRNSForm 8.3 - Ark Therapeutics Group PLC
15th Feb 201310:39 amPRNForm 8.3 - Ark Therapeutics Group plc
12th Feb 201312:25 pmRNSHolding(s) in Company
7th Feb 20133:05 pmRNSHolding(s) in Company
7th Feb 20131:41 pmPRNForm 8.3 - Ark Therapeutics Group
6th Feb 20134:43 pmRNSForm 8.3 - Ark Therapeutics
6th Feb 201311:18 amPRNForm 8.3 - Ark Therapeutics Group
6th Feb 201311:02 amRNSForm 8 (OPD)
5th Feb 20134:35 pmRNSPrice Monitoring Extension
5th Feb 20132:48 pmRNSForm 8.3 - Ark Therapeutics Group PLC
4th Feb 20132:43 pmRNSForm 8.3 - Ark Therapeutics Group Plc
4th Feb 20131:10 pmRNSForm 8.3 - Ark Therapeutics
4th Feb 201310:11 amRNSForm 8.3 - [Ark Therapeutics]
1st Feb 20133:10 pmRNSForm 8.3 - Ark Therapeutics Group PLC
1st Feb 20132:53 pmRNSForm 8.3 - Ark Therapeutics Amendment
1st Feb 201312:41 pmRNSForm 8.3 - Ark Therapeutics Group plc
31st Jan 20133:42 pmRNSForm 8.3 - Ark Therapeutics Group PLC
31st Jan 20131:40 pmRNSForm 8.3 - Ark Therapeutics Group Plc
31st Jan 20131:31 pmRNSForm 8.3 - Ark Therapeutics Group plc
31st Jan 201312:02 pmRNSForm 8.3 - ARK Therapeutics plc
31st Jan 201311:51 amBUSForm 8.3 - Ark Therapeutics Group Plc
31st Jan 201311:14 amPRNForm 8.3 - Ark Therapeutics Group
30th Jan 20134:03 pmRNSForm 8.3 - Ark Therapeutics Group Plc
30th Jan 20137:00 amRNSStrategic Review Update
24th Jan 20133:33 pmRNSHolding(s) in Company
21st Jan 20137:00 amRNSCompany Update
4th Dec 20123:40 pmRNSBlocklisting Six Monthly Return
30th Nov 20127:00 amRNSFrench Tax Credit for Research and Development
8th Nov 20127:00 amRNSInterim Management Statement
15th Oct 20127:00 amRNSRe Agreement
26th Sep 20127:00 amRNSManufacturing Agreement Update
29th Aug 20127:00 amRNSHalf Yearly Report
24th Aug 20124:40 pmRNSSecond Price Monitoring Extn
24th Aug 20124:35 pmRNSPrice Monitoring Extension
14th Aug 20127:00 amRNSRe Agreement
25th Jul 20127:00 amRNSManufacturing Partnership
5th Jul 20127:00 amRNSDirectorate Change
11th Jun 20127:00 amRNSAppointment of New Head of Business Development

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.